SCHEMBL6629977

SCHEMBL6629977

N#Cc1ccccc1Oc1ccc(C(N)=O)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP10 Q53GL7 9/20 0.60
MAPK14 Q16539 4/20 0.60
PARP15 Q460N3 4/20 0.59
PARP2 Q9UGN5 2/20 0.59
GAA P10253 2/20 0.59
POLB P06746 1/20 0.59
LPAR1 Q92633 1/20 0.56
LPAR5 Q9H1C0 1/20 0.56
KCNH2 Q12809 1/20 0.55
CYP3A4 P08684 1/20 0.55
PARP14 Q460N5 2/20 0.55
ALDH1A1 P00352 1/20 0.55
KMT2A Q03164 1/20 0.55
PARP16 Q8N5Y8 1/20 0.55
PARP11 Q9NR21 1/20 0.55
PARP4 Q9UKK3 1/20 0.55
EZH2 Q15910 1/20 0.52
TNKS O95271 1/20 0.51
TNKS2 Q9H2K2 1/20 0.51
NPC1 O15118 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14967208 0.86 LPAR1 (0.72) PARP10MAPK14PARP15GAAPOLB
SCHEMBL14018654 0.85 PARP10 (0.56) PARP10MAPK14PARP15PARP2GAA
SCHEMBL11498069 0.83 PARP10 (0.77) PARP10PARP15PARP2POLBCYP3A4
SCHEMBL8560809 0.82 POLB (0.65) MAPK14GAAPOLBLPAR1LPAR5
SCHEMBL3421693 0.81 POLB (0.79) MAPK14GAAPOLBLPAR1LPAR5
SCHEMBL6044963 0.81 PARP10 (0.57) PARP10MAPK14PARP15PARP2LPAR1
SCHEMBL18609418 0.79 MAPK14 (0.57) MAPK14GAAPOLBLPAR1LPAR5
SCHEMBL28550648 0.78 POLB (0.69) MAPK14GAAPOLBLPAR1LPAR5
SCHEMBL27868427 0.78 GAA (0.69) MAPK14GAAPOLBLPAR1LPAR5
SCHEMBL23657704 0.78 PARP1 (0.65) PARP10GAAALDH1A1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1480977-A2 SUBSTITUTED ARYL COMPOUNDS FOR TREATMENT OF DISEASE PHARMACIA & UPJOHN COMPANY (US) 2004-12-01 EP disclosed
WO-2003070728-A2 AZABICYCLO-SUBSTITUTED BENZOYLAMIDES AND THIOAMIDES FOR TREATMENT OF CNS-RELATED DISORDERS PHARMACIA & UPJOHN COMPANY (US) 2003-08-28 WO disclosed